Research on the Construction and Practice of Electronic Drug Package Insert Age-friendly Management System Under the Perspective of Intelligent Regulation

Expand
  • Jiangxi Medical Products Administration, Jiangxi Nanchang 330000, China

Received date: 2025-07-22

  Revised date: 2025-09-26

  Accepted date: 2025-11-27

  Online published: 2025-12-15

Abstract

With the accelerating aging process of China′s population, medication safety issues among the elderly have become increasingly prominent. Traditional drug package inserts with small fonts and complex medical terminology create widespread difficulties for elderly patients who “cannot see clearly and cannot understand” the information. In response to the national pilot policy for age-friendly and barrier-free reform of drug package inserts, Jiangxi Medical Products Administration took the lead in exploring the construction of an intelligent management system for electronic age-friendly drug package inserts. Based on the pilot practice in Jiangxi Province, this study systematically expounds the design concept, technical architecture, and core functions of the management system. The system adopts a “four-layer, three-terminal, one-cloud” architecture, integrating enterprise-side filing management, regulatory-side intelligent review, and user-side convenient service functions. It employs advanced technologies such as OCR recognition, AI voice synthesis, and the DeepSeek-R1 large model to achieve intelligent verification of insert content, voice broadcasting, and barrier-free inquiry services. The pilot operation results show that 132 varieties from 29 marketing authorization holders participated in the reform, with the system generating 294 electronic drug insert QR codes, effectively addressing barriers for elderly people in accessing medication information. The study summarizes and refines a replicable model of “policy guidance+technical support+collaborative division of labor”, validating the application value of digital means in pharmaceutical regulatory reform and providing practical examples and technical pathways for the nationwide promotion of age-friendly drug package insert reform.

Cite this article

XIONG Haiyan, XU Renen, RAO Long . Research on the Construction and Practice of Electronic Drug Package Insert Age-friendly Management System Under the Perspective of Intelligent Regulation[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2025 , 42(5) : 325 -325-331 . DOI: magtech-2025-07-22-00001

References

 [1] 周博雅,赵志刚,陆浩,等. 老年慢性病治疗药物中美药品说明书适老化信息对比分析[J]. 医药导报,2024,43(12):1936-1943.
     [2] 卢志坚,范伟义,宗申. 看不清的药品说明书,谁来管?[N]. 检察日报,2023-05-25(005).
     [3] FDA. Specific requirements on content and format of la-beling for human prescription drugs;addition of “Geriatric use” subsection in the labeling[EB/OL]. (1997-08-27) [2025-06-12]. https://www. federalregister. gov/documents/1997/08/27/97-22701/specific-requirements-on-content-and-format-of-labeling-for-human-prescription-drugs-addition-of “geriatric use” subsection in the labeling.
     [4] 王思懿,喻小勇,姜佳缘,等. 中美日药品说明书适老化管理的对比研究[J]. 中国药房,2025,36(9):1030-1034.
     [5] 厚生労働省. 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律施行規則[EB/OL]. (2020-09-29) [2025-06-12]. https://www. mhlw. go. jp/web/t_doc-dataId=81006000&dataType=0.
     [6] 梁银锋,王镝. 政务服务数字化转型何以提升公共服务效率?——以“互联网+政务服务”平台建设为例[J]. 电子政务,2024,(1):46-62.
     [7] 李骄阳,樊振佳,杨丽娟. 主动走向数字包容:老年人数字获得感的形成和作用机制[J]. 图书情报知识,2024,41(2):138-149.
     [8] 张虹倩,胡范铸. 药品标签信息无障碍化的分析框架与问题发现[J]. 语言战略研究,2024,9(4):23-33.
     [9] 国家药品监督管理局. 国家药监局关于发布《药品说明书适老化及无障碍改革试点工作方案》的公告[EB/OL]. (2023-10-31) [2025-06-14]. https://www. nmpa. gov. cn/xxgk/ggtg/ypggtg/ypqtggtg/20231031153424162. html.
     [10] 李茜茜,陆浩,武明芬,等. 基于Web of Science的药品说明书适老化研究文献计量学分析[J]. 中国药房,2024,35(2):231-236.
     [11] 林玉琴,赵杨,刘婉婷,等. 数字产品适老化研究综述:需求挖掘、障碍分析与优化设计[J]. 信息资源管理学报,2024,14(4):146-161.
     [12] 唐菀晨,顾淼. 浅谈电子药品说明书[J]. 中国食品药品监管,2023,(9):98-103,186.
     [13] 符晗,李沁怡. 基于用户动态需求的移动医疗APP适老化界面设计研究[J]. 包装工程,2024,45(20):392-401,432.
     [14] 王筱微,潘茜,黎漓. 药品说明书适老化设计与实施[J]. 科技视界,2024,14(30):15-16.
     [15] 文丽娟,高紫琦. 药品说明“适老化”改造还得加把劲[N]. 法治日报,2024-12-25(004).
     [16] 丛端端,耿莹,李强,等. 新药研发与临床研究中对于老年人群的若干考虑[J]. 中国医药工业杂志,2024,55(9):1282-1288.
     [17] 马若云. 健康传播视角下药品说明文本的易读性测量与适老化改造研究[D]. 西安外国语大学,2024.
     [18] 李海琦,蒋蓉,郑妤婕,等. 日本电子药品说明书管理实践及启示[J]. 中国新药与临床杂志,2024,43(12):904-910.
Outlines

/

[an error occurred while processing this directive]